Effects of high-flux hemodialysis and hemodiafiltration on the mortality of patients with end-stage kidney disease: a meta-analysis

CONCLUSIONS: Compared with HDF, HFHD has no obvious benefits for all-cause mortality or cardiovascular mortality in patients with ESKD, but reduced risk of infection-related death.PMID:37427760 | PMC:PMC10334859 | DOI:10.1080/0886022X.2022.2147436

Source: Renal Failure - July 10, 2023 Category: Urology & Nephrology Authors: Sihui Ma Nan Pu Juan Ma Source Type: research